J.ophthalmol.(Ukraine).2021;5:64-70.
http://doi.org/10.31288/oftalmolzh202156470
Received: 05 March 2021; Published on-line: 23 October 2021
Neopterin level in the anterior segment of the eye in induced uveitis with ocular hypertension when treated by dipeptide carnosine
I. M. Mykheitseva, N. V. Bondarenko, S. G. Kolomiichuk, N. B. Kuryltsiv
SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine; Odesa (Ukraine)
TO CITE THIS ARTICLE: Mykheitseva IM, Bondarenko NV, Kolomiichuk SG, Kuryltsiv NB. Neopterin level in the anterior segment of the eye in induced uveitis with ocular hypertension when treated by dipeptide carnosine. J.ophthalmol.(Ukraine).2021;5:64-70. http://doi.org/10.31288/oftalmolzh202156470
Background: We have previously demonstrated that the course of inflammatory process was significantly more severe in eyes with anterior uveitis with ocular hypertension (OHT) than in those with anterior uveitis with normal intraocular pressure (IOP), which was largely due to a more marked activation of enzymes producing active oxygen as well as peroxidative processes in uveal structures of experimental animals. Aside from oxidative stress characteristics, our attention has been drawn to neopterin as a potential marker of inflammation severity and the efficacy of inflammation control. Because there is a paucity of reports focused on the potential for using this characteristic as a diagnostic criterion in ocular disorders, especially in uveitis with raised IOP, studies on this subject are important.
Purpose: To assess the impact of dipeptide carnosine on the level of neopterin in the rabbit’s anterior eye segment in anterior uveitis with ocular hypertension.
Material and Methods: Forty-four Chinchilla rabbits (88 eyes) were divided into 4 experimental groups (group 1, 10 animals with induced OHT only; group 2, 10 animals with induced experimental non-infectious uveitis only; group 3, 12 animals with OHT induced prior to experimental non-infectious uveitis; group 4, 12 animals treated with carnosine for experimental uveitis with OHT). Rabbits of group 4 received 5% carnosine solution into the conjunctival sac, twice daily for the four weeks. The control group comprised 9 intact rabbits. Neopterin enzyme-linked immunosorbent assay kit was used to determine neopterin levels in uveal tract tissue, aqueous humor and tear samples according to the manufacturer’s instructions. Statistica 5.5 (StatSoft, Tulsa, OK, USA) software and parametric statistical tests were used for statistical analysis.
Results: Neopterin levels in uveal tract tissue, aqueous humor and tear samples taken from rabbit’s eyes with induced OHT only were increased compared to controls but lower than those in non-infectious uveitis only. Neopterin levels in uveal tract tissue, aqueous humor and tear samples from rabbit’s eyes with induced both anterior uveitis and OHT (group 3) were 5.2-, 3.7- and 2.4 times higher, respectively, than in controls, and 42.5% (р < 0.05), 28.5% (р < 0.05) and 23.6% (р < 0.05) higher, respectively, than in samples taken from rabbit’s eyes of group 2. The carnosine treatment of induced both anterior uveitis and OHT (group 4) contributed to reduced levels of neopterin is samples under study, with neopterin levels in uveal tract tissue, aqueous humor and tear fluid being 39.4%, 38.9% and 30.2% lower, respectively, than in samples taken from rabbit’s eyes of group 3 (anterior uveitis plus OHT without treatment) (р < 0.01), and 3.2-, 2.2- and 1.7 times higher, respectively, than in controls (р < 0.001).
Conclusion: High neopterin levels in the uveal tract tissues and anterior chamber aqueous fluid indicated its impact on the course of inflammation in animals with induced uveitis only and especially in those with induced both uveitis and OHT. A high neopterin level in the tear fluid in anterior uveitis can be considered a diagnostic marker of the severity of inflammation in the anterior segment of the eye. The carnosine treatment statistically significantly reduced neopterin levels in the uveal tract tissues, anterior chamber aqueous fluid and tear fluid in rabbit’s eyes with induced both uveitis and OHT. The changes in neopterin levels were caused by a reduction in the severity of inflammation in the anterior segment of the eye.
Keywords: non-infectious uveitis, ocular hypertension, neopterin, carnosine, rabbits
References
1. Katargina LA, Khvatova AV. [Endogenous uveitis in children and adolescents]. Moscow: Meditsina; 2000. Russian.
2. Gonzalez MM, Solano MM, Porco TC, et al. Epidemiology of uveitis in a US population-based study. J Ophthalmic Inflamm Infect. 2018 Apr 17;8(1):6.
3. Chang JH, Wakefield D. Uveitis: A global perspective. 2002 Dec;10(4):263-79.
4. Durrani OM, Meads CA, Murray PI. Uveitis: A Potentially Blinding Disease. Ophthalmologica. 2004;218:223-36. Crossref PubMed
5. Anesi SD, Foster CS. Anterior uveitis: etiology and treatment. Advanced Ocular Care. 2011;2:32-4.
6. Drozdova EA. [Issues of the classification and epidemiology of uveitis]. RMZh. Klinicheskaia Oftalmologiia. 2016;3:155-9. Russian.
7. Hosseini SM, Shoeibi N, Ebrahimi R, Ghasemi M. Patterns of Uveitis at a Tertiary Referral Center in Northeastern Iran. J Ophthalmic Vis Res. Apr-Jun 2018;13(2):138-43.
8. Aman R, Engelhard SB, Bajwa А, et al. Ocular hypertension and hypotony as determinates of outcomes in uveitis. Clin Ophthalmol. 2015 Dec 7;9: 2291-8.
9. Baneke AJ, Lim KS, Stanford М. The Pathogenesis of Raised Intraocular Pressure in Uveitis. Curr Eye Res. 2016;41(2):137-49.
10. Krasnozhan OV, Lutsenko NS, Zhaboiedov DG, Efimenko NF. [Features of the systemic expression profile of interleukins in patients with glaucoma and moderate myopia]. Oftalmologiia. Vostochnaia Evropa. 2019;4:471-80.
11. Ielskii VN, Mikheitseva IN. [Dysregulatory aspects of the glaucomatous process (review of the literature and own investigations]. Zhurnal NAMN Ukrainy. 2011;17(3):235-44. Russian.
12. Yadav UCS, Kalarya NM, Ramana KV. Emerging role of antioxidants in the protection of uveitis complications. Curr Med Chem. 2011;18(6):931-42.
13. Chesnokova NB, Neroev VV, Beznos OV, et al. [Oxidative stress in uveitis and its correction with superoxide dismutase antioxidative enzyme (experimental study)]. Vestn Oftalmol. Sep-Oct 2014;130(5):30-4.
14. Sunil SA, Wei J, Qian J, et al. Aqueous humor protein dysregulation in primary angle-closure glaucoma. Int Ophthalmol. 2019;39(4):861-71.
15. Mykheitseva IM, Bondarenko NV, Kolomiichuk SG, Siroshtanenko TI. Clinical picture of uveitis in the presence of ocular hypertension and improvement in disease course with dipeptide carnosine. J Ophthalmol (Ukraine). 2021; 1:55-61.
16. Mykheitseva IM, Bondarenko NV, Kolomiichuk SG, Siroshtanenko TI. State of oxidation and peroxidation in rabbit’s uveal tract tissues in induced uveitis and ocular hypertension. J Ophthalmol (Ukraine). 2019;2:55-60.
17. Ooi KGJ, Galatowicz G, Calder VL, Lightman SL. Cytokines and chemokines in uveitis – is there a correlation with clinical phenotype? Clin Med Res. 2006 Dec;4(4):294-309.
18. Takase H, Sugita S, Taguchi С, et al. Capacity of ocular infiltrating T helper type 1 cells of patients with non-infectious uveitis to produce chemokines. Br J Ophthalmol. 2006 Jun;90(6):765-8.
19. Karaulov AV, Kaliuzhin OV. [Cytokines: biological action and clinical applications]. Uspekhi klinicheskoi immunologii i allergologii. Moscow: RAEN. 200;1:193-205. Russian.
20. Dikinov ZKh. [Molecular markers of inflammation in endogenous uveitis]. Immunopatologiia, allergologiia, infektologiia. 2013;3:22-26. Russian.
21. Sviridov EA, Telegina TA. [Neopterin and its reduced forms: biological role and participation in cellular immunity]. Uspekhi biologicheskoi khimii. 2005;45:355-390. Russian.
22. Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010;120(9):3073-83.
23. Serif N, Gurelik G, Hasanreisoglu M, et al. Evaluation of Neopterin Levels in an Endotoxin-Induced Experimental Uveitis Model. Semin Ophthalmol. 2016;31(3):256-60.
24. Onishchenko AL, Kolbasko AV, Chernysheva AD, Surzhikova GS. [The value of neopterin in etiological diagnosis of endogenous uveitis]. Vestn Oftalmol. Mar-Apr 2011;127(2):25-9. Russian.
25. Palabiyik SS, Keles S, Girgin G, еt al. Neopterin Release and Tryptophan Degradation in Patients with Uveitis. Current Eye Res. 2016;41(11):1513-7.
26. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008 Aug;17(5):350-5.
27. Krakhmaleva DA, Pivin EA, Trufanov SV, Malozhen SA. [Modern opportunities in uveitis treatment] Ophthalmology in Russia. 2017;14(2):113-119. (In Russ.)
28. Volkov OA. [Biological role of carnosine and its use in ophthalmology (mini-review)]. Biomed Khim. Sep-Oct 2005;51(5):481-4.
29. Information Bulletin No. 19 issued 10.10.2019, based on Pat. of Ukraine №137,107; MPK (2019.01) А61К 9/00. [Method for inducing non-infectious uveitis in the presence of ocular hypertension]. Authors: Mykheitseva IM, Kolomiichuk SG, Bondarenko NV, Siroshtanenko TI. Owner: State Institution Filatov Institute of Eye Diseases and Tissue Therapy, NAMS of Ukraine.
30. Mykheitseva IM, Bondarenko NV, Kolomiichuk SG, et al. The effect of high intraocular pressure on enzymatic antioxidant system of uveal tissues in rabbits with experimental allergic uveitis. J Ophthalmol (Ukraine). 2019;4:57-63.
31. Smukowska-Gorynia A, Marcinkowska J, Chmara E, et al. Neopterin as a biomarker in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respiration. 2018;96(3):222–30.
32. Kashyap В, Goyal N, Das GK, et al. Ophthalmic Presentation of Disseminated Tuberculosis with Relapse-Immunological Profile. Ind J Clin Biochem. 2018 Oct;33(4):483-6.
33. Prasanna JS, Sumadhura C, Karunakar P. Neopterin as a diagnostic biomarker for diagnosis of inflammatory diseases like periodontitis. J Oral Res Rev. 2017;9:45-9.
34. Zenkov NK, Lankin VZ, Menshchikova EB. [Oxidative stress: Biochemical and pathophysiological aspects]. Moscow: MAIK Nauka/Interperiodica; 2001. Russian.
35. Khurtsilava OG, Pluzhnikov NN, Nakatis IaA, editors. [Oxidative stress and inflammation: a pathogenetic partnership]. St Petersburg: Mechnikov North Western State Medical University Publishing House; 2012. Russian.
36. Maichuk IuF, Kurenkov VV, Maichuk DIu, et al. [Efficacy of carnosine eye drops in corneal therapy and excimer laser surgery]. Oftalmol Zh. 2000;4:24-5. Russian.
37. Boldyrev AA, Aldini G, Derave W. Physiology and pathophysiology of carnosine. Physiol Rev. 2013 Oct;93(4):1803-45.
38. Boldyrev AA, Stvolinsky SL, Fedorova TN. [Carnosine: endogenous physiological corrector of antioxidative system activity]. Usp Fiziol Nauk. Jul-Sep 2007;38(3):57-71.
39. Shekhter AB, Silaieva SA, Aboiants RK, et al. [A method of wound treatment]. Certificate of authorship No. 491184/14, USSR; 1991. Russian.
40. Perelman MI, Kornilova ZKh, Paukov VS, et al. [Impact of carnosine on lung wound healing]. Biulleten eksperimentalnoi i biologicheskoi meditsiny. 1989;108(9):352-5. Russian.
41. Seleznev DA. [Use of carnosine for the prevention and treatment of periodontal inflammatory disease in orthopedic treatment]. Thesis for the Degree of Cand Sc (Med). Moscow;2006. Russian.
Conflict of Interest:
Authors declare that there are no conflicts of interest that might influence their opinion on the subject matter or materials described or discussed in this manuscript.